| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139872A1 Novel antibiotics |
| 01/06/2010 | EP2139854A2 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 01/06/2010 | EP2139524A1 Multivalent heterobifunctional polymers and methods of their use |
| 01/06/2010 | EP2139514A1 Artificial invaplex |
| 01/06/2010 | EP2139511A1 Pharmaceutical composition comprising a cytokine |
| 01/06/2010 | EP2139474A2 Transcription factor modulating compounds and methods of use thereof |
| 01/06/2010 | EP2139463A2 Anti-infective agents |
| 01/06/2010 | EP2056820B1 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof |
| 01/06/2010 | EP2038275B1 Novel pyridazine compound and use thereof |
| 01/06/2010 | EP1687015B1 Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
| 01/06/2010 | EP1558611B1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | EP1032417B1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/06/2010 | EP0963197B1 Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/06/2010 | CN100578214C Method for controlling antiviral oral liquid |
| 01/06/2010 | CN100577806C Recombinant plasmid and engineering bacterium containing grass carp interferon gene and their application |
| 01/06/2010 | CN100577685C Long-acting thymosin alpha1 polyethylene glycol modifier |
| 01/06/2010 | CN100577679C L-nucleoside prodrug |
| 01/06/2010 | CN100577678C Macrolide analogue drug double sidechain illotycin A derivative, synthesis method and uses |
| 01/06/2010 | CN100577655C Andrographolidi natrii bisulfis and preparation method thereof |
| 01/06/2010 | CN100577205C Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions prepared therefrom |
| 01/06/2010 | CN100577204C Method for producing swine fever live vaccine with cell line |
| 01/06/2010 | CN100577182C Emulsion containing aucklandia root oil, its preparation process and use |
| 01/06/2010 | CN100577181C Extraction of herbs by heating alcohol |
| 01/06/2010 | CN100577179C Application of chitin, chitosan and their derivatives in preparing antivirotic |
| 01/06/2010 | CN100577178C Soft capsules containing roxithromycin |
| 01/06/2010 | CN100577173C Adefovir dipivoxil self-emulsifiable preparation and its preparing method |
| 01/06/2010 | CN100577164C Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 01/06/2010 | CN100577144C Topical formulation for prevention and treatment of acne |
| 01/05/2010 | US7642367 Diamino-functional chalcones |
| 01/05/2010 | US7642350 Purine derivatives |
| 01/05/2010 | US7642280 Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
| 01/05/2010 | US7642265 Benzimidazoles and analogs thereof as antivirals |
| 01/05/2010 | US7642251 Compounds for the treatment of hepatitis C |
| 01/05/2010 | US7642243 Administering C-type natriuretic peptide, guanyl cyclase (GC-B)-activating peptide |
| 01/05/2010 | US7642235 Macrocyclic peptides active against the hepatitis C virus |
| 01/05/2010 | US7642228 Method for making heteromultimeric polypeptides |
| 01/05/2010 | US7641910 Amino acid sequence or immunogenic fragment of at least 15 contiguous amino acid sequence when administered to a subject induce antibody or T-cell mediated immune response that recognizes polypeptide |
| 01/05/2010 | US7641909 Nonstructural and nonstructural proteins from attenuated dengue-2 virus, and structural protein from West Nile virus; vaccines |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 01/05/2010 | CA2456183C Il-6/ds-sil-6r fusion protein |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2425319C Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 01/05/2010 | CA2424512C Delivery system and method of treating or preventing otitis media |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 01/05/2010 | CA2332642C Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 01/05/2010 | CA2260759C Recombinant swinepox virus |
| 12/31/2009 | US20090326218 Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326031 Antiviral use of cationic surfactant |
| 12/31/2009 | US20090326030 Use of Levo-Ornidazole in the Preparation of Anti-Anaerobic Bacteria Infection Drugs |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090326019 3,4-bicyclic pyrrolidine antivirals |
| 12/31/2009 | US20090325983 New purine derivatives |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325966 s-Triazine compounds, pharmaceutical compositions and method of using the same |
| 12/31/2009 | US20090325955 Gyrase inhibitors and uses thereof |
| 12/31/2009 | US20090325935 Gyrase inhibitors and uses thereof |
| 12/31/2009 | US20090325908 9-substituted minocycline compounds |
| 12/31/2009 | US20090325904 Maleic acid monosalt of antiviral agent and pharmaceutical composition containing the same |
| 12/31/2009 | US20090325902 Heterocyclic urea derivatives and methods of use thereof |
| 12/31/2009 | US20090325889 Hepatitis c serine protease inhibitors and uses therefor |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325875 Muteins of human tear lipocalin |
| 12/31/2009 | US20090325228 Fungal cell wall synthesis gene |
| 12/31/2009 | US20090324723 Method of prophylaxis of infection |
| 12/31/2009 | US20090324707 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 12/31/2009 | US20090324694 Gastroretentive drug delivery system comprising an extruded hydratable polymer |
| 12/31/2009 | US20090324668 Implant, its uses and methods for making it |
| 12/31/2009 | US20090324648 Vaccine for edwardsiella disease and streptococcal disease in fish |
| 12/31/2009 | US20090324638 Live bacterial vaccine |
| 12/31/2009 | US20090324635 Caspofungin free of caspofungin impurity A |
| 12/31/2009 | US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 12/31/2009 | US20090324623 Two-component genome flavivirus and uses thereof |
| 12/31/2009 | US20090324593 Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof |
| 12/31/2009 | US20090324577 6-11 Bicyclic Ketolide Derivatives |
| 12/31/2009 | US20090324553 Chimeric Viral Envelopes |
| 12/31/2009 | US20090324544 Substituted cyclic pyrrolidine derivatives |
| 12/31/2009 | US20090324543 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
| 12/31/2009 | US20090324541 Prophylactic or therapeutic agent for viral disease |
| 12/31/2009 | US20090324517 Halitosis treatment |
| 12/31/2009 | US20090324512 Polypeptide constructs for nasal administration |
| 12/31/2009 | US20090324503 Methods for detecting a mycobacterium tuberculosis infection |
| 12/31/2009 | US20090324501 Vaccine Carrier |
| 12/30/2009 | WO2009158396A1 Diketopiperidine derivatives as hiv attachment inhibitors |
| 12/30/2009 | WO2009158394A1 Diketo azolopiperidines and azolopiperazines as anti-hiv agents |
| 12/30/2009 | WO2009158364A1 Regulated genetic suicide mechanism compositions and methods |
| 12/30/2009 | WO2009158284A2 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
| 12/30/2009 | WO2009158034A1 Caspofungin free of caspofungin impurity a |
| 12/30/2009 | WO2009158026A1 Hydrazonamide compounds that modulate hsp90 activity |
| 12/30/2009 | WO2009157423A1 Oxazolidinone derivative having fused ring |
| 12/30/2009 | WO2009156966A1 Benzothiazoles and aza-analogues thereof use as antibacterial agents |
| 12/30/2009 | WO2009156962A1 Oral herbal composition for the treatment of oral candidiasis |
| 12/30/2009 | WO2009156859A1 Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives |
| 12/30/2009 | WO2009156307A1 Probiotics, secretory iga and infection |
| 12/30/2009 | WO2009156301A1 Probiotics, secretory iga and inflammation |